Vertex Pharmaceuticals | VRTX - Debitur Perdagangan

Harga Saham
435.87
Perubahan Harian
-0.71 -0.16%
Bulanan
-0.75%
Tahunan
-2.53%
Q2 Perkiraan
428.17




Debitur Perdagangan Perubahan Tanggal
AbbVie USD 12.59B 180M 2025-12
Acadia Pharmaceuticals USD 148.38M 153K 2026-03
Agios Pharmaceuticals USD 16.13M 5.56M 2026-03
Alnylam Pharmaceuticals USD 883.96M 106.39M 2026-03
Amgen USD 9.14B 432M 2026-03
Arrowhead Research USD 15.68M 203.19M 2026-03
Biogen USD 1.79B 76.6M 2026-03
BioMarin Pharmaceutical USD 903.91M 4.3M 2026-03
Bristol-Myers Squibb USD 14.36B 164M 2026-03
Gilead Sciences USD 4.74B 172M 2026-03
Incyte USD 1.05B 27.09M 2026-03
Insmed USD 178.55M 37.7M 2026-03
Ionis Pharmaceuticals USD 74M 8M 2026-03
J&J USD 21.33B 3.72B 2025-12
Merck USD 11.78B 345M 2025-12
Moderna USD 71M 113M 2026-03
Neurocrine Biosciences USD 768.1M 81.3M 2026-03
Novartis USD 9.6B 2.69B 2026-03
Pfizer USD 16.17B 332M 2026-03
PTC Therapeutics USD 181.62M 21.45M 2025-12
Puma Biotechnology USD 28.1M 3.52M 2024-06
Regeneron Pharmaceuticals USD 5.73B 10.1M 2026-03
Roche Holding CHF 11.9B 460M 2025-12
Sangamo BioSciences USD 581K 110K 2024-06
Sanofi EUR 482M 85M 2026-03
Sarepta Therapeutics USD 547.91M 149.68M 2026-03
Ultragenyx Pharmaceutical USD 60M 98M 2026-03
United Therapeutics USD 312M 38.2M 2026-03
Vertex Pharmaceuticals USD 2B 56.7M 2026-03